Telomerase directly regulates NF-B-dependent transcription

Nature Cell Biology

Volumn 14, Issue 12, 2012, Pages 1270-1281

  Ghosh, Arkasubhra ^a   Saginc, Gaye ^b   Leow, Shi Chi ^a   Khattar, Ekta ^a   Shin, Eun Myong ^a   Yan, Ting Dong ^c   Wong, Marc ^a   Zhang, Zhizhuo ^d   Li, Guoliang ^b   Sung, Wing Kin ^b,d   Zhou, Jianbiao ^e   Chng, Wee Joo ^e   Li, Shang ^c   Liu, Edison ^b   Tergaonkar, Vinay ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TELOMERASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TELOMERASE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84870616090     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2621     Document Type: Article

References (70)

1. Blackburn, E. H. et al. Recognition and elongation of telomeres by telomerase. Genome 31, 553-560 (1989). (Pubitemid 20118437)
2. Counter, C. M. et al. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc. Natl Acad. Sci. USA 95, 14723-14728 (1998). (Pubitemid 29003697)
3. Hay-ick, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37, 614-636 (1965).
4. Verdun, R. E. & Karlseder, J. Replication and protection of telomeres. Nature 447, 924-931 (2007). (Pubitemid 46975759)
5. Shay, J. W. & Wright, W. E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 26, 867-874 (2005). (Pubitemid 41214314)
6. Harley, C. B. Telomerase and cancer therapeutics. Nat. Rev. Cancer 8, 167-179 (2008). (Pubitemid 351305939)
7. Chang, S. & DePinho, R. A. Telomerase extracurricular activities. Proc. Natl Acad. Sci. USA 99, 12520-12522 (2002).
8. Gordon, D. M. & Santos, J. H. The emerging role of telomerase reverse transcriptase in mitochondrial DNA metabolism. J. Nucl. Acids http://dx.doi.org/10.4061/2010/390791 (2010).
9. Maida, Y. et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461, 230-235 (2009).
10. Martinez, P. & Blasco, M. A. Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins. Nat. Rev. Cancer 11, 161-176 (2011).
11. Sarin, K. Y. et al. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436, 1048-1052 (2005). (Pubitemid 41191691)
12. Smith, L. L., Coller, H. A. & Roberts, J. M. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5, 474-479 (2003). (Pubitemid 36592272)
13. Stewart, S. A. et al. Telomerase contributes to tumorigenesis by a telomere length- independent mechanism. Proc. Natl Acad. Sci. USA 99, 12606-12611 (2002).
14. Li, S., Crothers, J., Haqq, C. M. & Blackburn, E. H. Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA. J. Biol. Chem. 280, 23709-23717 (2005). (Pubitemid 40884853)
15. Artandi, S. E. et al. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl Acad. Sci. USA 99, 8191-8196 (2002). (Pubitemid 34651028)
16. Blasco, M. A., Rizen, M., Greider, C. W. & Hanahan, D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet. 12, 200-204 (1996). (Pubitemid 26051303)
17. Cosme-Blanco, W. et al. Telomere dysfunction suppresses spontaneous tumorige- nesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep. 8, 497-503 (2007). (Pubitemid 46696521)
18. Gonzalez-Suarez, E. et al. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20, 2619-2630 (2001). (Pubitemid 32938547)
19. Gizard, F. et al. Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by in-ammatory stimuli in macrophages. Arterioscler Thromb. Vasc. Biol. 31, 245-252 (2011).
20. Mitchell, J. R., Wood, E. & Collins, K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551-555 (1999).
21. Shkreli, M. et al. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nature Med. 18, 111-119 (2011).
22. Park, J. I. et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460, 66-72 (2009).
23. Indran, I. R., Hande, M. P. & Pervaiz, S. hTERT overexpression alleviates intracellular ROS production, improves mitochondrial function, and inhibits ROS-mediated apoptosis in cancer cells. Cancer Res. 71, 266-276 (2011).
24. Mukherjee, S., Firpo, E. J., Wang, Y. & Roberts, J. M. Separation of telomerase func-tions by reverse genetics. Proc. Natl Acad. Sci. USA 108, E1363-E1371 (2011).
25. Masutomi, K. et al. The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl Acad. Sci. USA 102, 8222-8227 (2005). (Pubitemid 40800070)
26. Joseph, I. et al. The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. Cancer Res. 70, 9494-9504 (2010).
27. Nitta, E. et al. Telomerase reverse transcriptase protects ATM-de-cient hematopoi- etic stem cells from ROS-induced apoptosis through a telomere-independent mechanism. Blood 117, 4169-4180 (2011).
28. Ren, J. G. et al. Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung -broblasts. FEBS Lett. 488, 133-138 (2001).
29. Perkins, N. D. The diverse and complex roles of NF-B subunits in cancer. Nat. Rev. Cancer 12, 121-132 (2012).
30. Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-B signaling pathways. Nature Immunol. 12, 695-708 (2011).
31. Hayden, M. S. & Ghosh, S. Shared principles in NF-B signaling. Cell 132, 344-362 (2008).
32. Basseres, D. S., Ebbs, A., Levantini, E. & Baldwin, A. S. Requirement of the NF-B subunit p65/RelA for K-Ras-induced lung tumorigenesis. Cancer Res. 70, 3537-3546 (2010).
33. Loercher, A. et al. Nuclear factor-B is an important modulator of the altered gene expression pro-le and malignant phenotype in squamous cell carcinoma. Cancer Res. 64, 6511-6523 (2004). (Pubitemid 39297908)
34. DeNardo, D. G., Johansson, M. & Coussens, L. M. In-aming gastrointestinal oncogenic programming. Cancer Cell 14, 7-9 (2008).
35. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related in-ammation. Nature 454, 436-444 (2008).
36. Pikarsky, E. et al. NF-B functions as a tumour promoter in in-ammation-associated cancer. Nature 431, 461-466 (2004). (Pubitemid 39329586)
37. Jones, R. L. et al. Nuclear NF-B/p65 expression and response to neoadjuvant chemotherapy in breast cancer. J. Clin. Pathol. 64, 130-135 (2011).
38. Teo, H. et al. Telomere-independent Rap1 is an IKK adaptor and regulates NF-B-dependent gene expression. Nat. Cell Biol. 12, 758-767 (2010).
39. Ben-Neriah, Y. & Karin, M. In-ammation meets cancer, with NF-B as the matchmaker. Nature Immunol. 12, 715-723 (2011).
40. Wu, Z. H. et al. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol. Cell 40, 75-86 (2010).
41. Perkins, N. D. Integrating cell-signalling pathways with NF-B and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62 (2007). (Pubitemid 46012014)
42. Saccani, S., Marazzi, I., Beg, A. A. & Natoli, G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor -B response. J. Exp. Med. 200, 107-113 (2004). (Pubitemid 38924733)
43. Chew, J. et al. WIP1 phosphatase is a negative regulator of NF-B signalling. Nat. Cell Biol. 11, 659-666 (2009).
44. Cabannes, E., Khan, G., Aillet, F., Jarrett, R. F. & Hay, R. T. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IBα. Oncogene 18, 3063-3070 (1999). (Pubitemid 29261226)
45. Ngo, V. N. et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 470, 115-119 (2011).
46. Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108-112 (2009).
47. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-B. Science 274, 787-789 (1996).
48. Seimiya, H. et al. Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. Mol. Cancer Ther. 1, 657-665 (2002).
49. Barkett, M. & Gilmore, T. D. Control of apoptosis by Rel/NF-B transcription factors. Oncogene 18, 6910-6924 (1999).
50. Pfeffer, K. et al. Mice de-cient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467 (1993). (Pubitemid 23143346)
51. Dejager, L. & Libert, C. Tumor necrosis factor - mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice. Cytokine 42, 55-61 (2008).
52. Yin, L., Hubbard, A. K. & Giardina, C. NF-B regulates transcription of the mouse telomerase catalytic subunit. J. Biol. Chem. 275, 36671-36675 (2000). (Pubitemid 32002070)
53. Vanden Berghe, W., De Bosscher, K., Boone, E., Plaisance, S. & Haegeman, G. The nuclear factor-B engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J. Biol. Chem. 274, 32091-32098 (1999).
54. Rentoukas, E. et al. Connection between telomerase activity in PBMC and markers of in-ammation and endothelial dysfunction in patients with metabolic syndrome. PLoS One 7, e35739 (2012).
55. Goytisolo, F. A. et al. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med. 192, 1625-1636 (2000).
56. Ping, L., Asai, A., Okada, A., Isobe, K. & Nakajima, H. Dramatic increase of telomerase activity during dendritic cell differentiation and maturation. J. Leukoc. Biol. 74, 270-276 (2003). (Pubitemid 38040424)
57. Bodnar, A. G., Kim, N. W., Effros, R. B. & Chiu, C. P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228, 58-64 (1996). (Pubitemid 26349713)
58. Ogoshi, M., Takashima, A. & Taylor, R. S. Mechanisms regulating telomerase activity in murine T cells. J. Immunol. 158, 622-628 (1997). (Pubitemid 127492638)
59. Eaton, K. A., Opp, J. S., Gray, B. M., Bergin, I. L. & Young, V. B. Ulcerative typhlocolitis associated with Helicobacter mastomyrinus in telomerase-de-cient mice. Vet. Pathol. 48, 713-725 (2011).
60. Chu, C., Qu, K., Zhong, F. L., Artandi, S. E. & Chang, H. Y. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol. Cell 44, 667-678 (2011).
61. Gilbert, L. A. & Hemann, M. T. DNA damage-mediated induction of a chemoresistant niche. Cell 143, 355-366 (2010).
62. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-674 (2011).
63. Li, S. et al. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res. 64, 4833-4840 (2004). (Pubitemid 38924527)
64. Tergaonkar, V., Correa, R. G., Ikawa, M. & Verma, I. M. Distinct roles of I-B proteins in regulating constitutive NF-B activity. Nat. Cell Biol. 7, 921-923 (2005). (Pubitemid 41486295)
65. Fujita, P. A. et al. The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39, D876-882 (2011).
66. Xu, H. et al. A signal-noise model for significance analysis of ChIP-seq with negative control. Bioinformatics 26, 1199-1204 (2010).
67. Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996-1006 (2002).
68. Zhang, Z., Chang, C. W., Goh, W. L., Sung, W. K. & Cheung, E. CENTDIST: discovery of co-associated factors by motif distribution. Nucleic Acids Res. 39, W391-W399 (2011).
69. Simonet, T. et al. The human TTAGGG repeat factors 1 and 2 bind to a subset of interstitial telomeric sequences and satellite repeats. Cell Res. 21, 1028-1038 (2011).
70. McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495-501 (2010).